Rep. Joe Cunningham. Photo: Sean Rayford/Getty Images

Rep. Joe Cunningham (D-S.C.) has tested positive for COVID-19, the freshman congressman revealed publicly on Friday.

Where it stands: The 37-year-old is the third known member of the House to contract the virus, after Rep. Mario Diaz-Balart (R-Fla.) and Rep. Ben McAdams (D-Utah) announced they tested positive last week. Sen. Rand Paul (R-Ky.) is the only known senator to have tested positive.

Details: Cunningham said he lost his sense of smell and taste on March 17, but only discovered this week that those were symptoms associated with the virus. He entered self-quarantine on March 19 after the congressional physician said he had been in contact with someone known to have the virus. Cunningham received his result on Friday.

"I am grateful that my family remains in good health and urge South Carolinians to follow the guidelines and recommendations from the CDC and other health experts so that we can recover from this public health threat."
— Rep. Joe Cunningham in a statement

Go deeper

Updated 20 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Chris Christie: Wear a mask "or you may regret it — as I did" — Senate Democrats block vote on McConnell's targeted relief bill.
  2. Business: New state unemployment filings fall.
  3. Economy: Why the stimulus delay isn't a crisis (yet).
  4. Health: FDA approves Gilead's remdesivir as a coronavirus treatment How the pandemic might endMany U.S. deaths were avoidable.
  5. Education: Boston and Chicago send students back home for online learning.
  6. World: Spain and France exceed 1 million cases.

FBI: Russian hacking group stole data after targeting local governments

FBI Headquarters. Photo: Mark Wilson/Getty Images

Energetic Bear, a Russian state-sponsored hacking group, has stolen data from two servers after targeting state and federal government networks in the U.S. since at least September, the FBI and Cybersecurity and Infrastructure Security Agency said on Thursday.

Driving the news: Director of National Intelligence John Ratcliffe announced Wednesday that Iran and Russia had obtained voter registration information that could be used to undermine confidence in the U.S. election system.

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.